[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-349950-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-349950-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","cldn7-epithelial-gatekeeper-from-physiology-to-pathology-roles-in-cancer-and-epithelial-related-diseases-review","CLDN7: Epithelial gatekeeper from physiology to pathology - roles in cancer and epithelial-related diseases - Review","","Claudin-7 (CLDN7) is a key component of epithelial tight junctions, essential for maintaining cell polarity, barrier integrity, and paracellular transport. Abnormal CLDN7 expression is closely linked to disease onset and progression and is strongly associated with the growth and metastasis of multiple cancers. Dysregulated CLDN7 also contributes to intestinal, skin, and respiratory system disorders. This review summarizes CLDN7 structure, expression, physiological functions, stability, and regulatory mechanisms, emphasizing tumor roles and discussing clinical significance.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/cldn7-epithelial-gatekeeper-from-physiology-to-pathology-roles-in-cancer-and-epithelial-related-diseases-review/349950/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/cldn7-epithelial-gatekeeper-from-physiology-to-pathology-roles-in-cancer-and-epithelial-related-diseases-review/349950.png","ImageObject",300,407,{"name":42,"@type":43},"Aurelia","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the primary biological role of CLDN7 in epithelial cells?","Question",{"text":63,"@type":64},"CLDN7 is a key component of epithelial tight junctions and helps maintain cell polarity, barrier integrity, and paracellular transport.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How is abnormal CLDN7 expression related to cancer?",{"text":68,"@type":64},"Abnormal CLDN7 expression is closely associated with the growth and metastasis of multiple cancers, and the review highlights its tumor-related expression patterns and regulatory mechanisms.",{"name":70,"@type":61,"acceptedAnswer":71},"Which non-neoplastic diseases are associated with dysregulated CLDN7?",{"text":72,"@type":64},"The review links dysregulated CLDN7 to intestinal, skin, and respiratory system diseases, including examples such as colitis, psoriasis, and respiratory disorders.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},349950,1790323281,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1099514068365,"https://ap-avatar.wpscdn.com/avatar/10000253d8d9f28188e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1794309523707217728","INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 57: 110, 2026  \nCLDN7: Epithelial gatekeeper from physiology to pathology‑roles in cancer and epithelial‑related diseases (Review)  \nXIUPING LAI 1* , YAN YAN 1* , LU SUN 1 , ZILI LEI2 and YANHONG YANG 1  \n1The First Affiliated Hospital (The First School of Clinical Medicine), Guangdong Pharmaceutical University, Guangzhou, Guangdong 510080, P.R. China; 2Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine, Guangdong Pharmaceutical University, Guangzhou, Guangdong 510006, P.R. China  \nReceived December 1, 2025; Accepted February 10, 2026  \nDOI: 10.3892/ijmm.2026.5781  \nAbstract. Claudin‑7 (CLDN7) is a key component of epithelial tight junctions. It plays a vital role in maintaining cell polarity, barrier integrity and paracellular transport . Abnormal CLDN7 expression is closely related to the onset and progression of various diseases . It is especially mark‑ edly associated with the growth and metastasis of multiple cancers . Additionally, dysregulated CLDN7 expression contributes to the progression of intestinal, skin and respira‑ tory system diseases . The present review summarized the structure, expression, physiological functions, stability and regulatory mechanisms of CLDN7, emphasizing its role in tumors . The expression patterns, regulatory mechanisms, effect on malignant phenotypes and clinical significance of CLDN7 were also discussed.  \nContents  \n1. Introduction  \n2. Methods  \n3. Structure  \n4. Expression and regulation of CLDN7  \nCorrespondence to: Professor Yanhong Yang, The First Affiliated Hospital (The First School of Clinical Medicine), Guangdong Pharmaceutical University, 19 Nong‑Lin‑Xia Road, Yue‑Xiu, Guangzhou, Guangdong 510080, P.R. China  \nE‑mail: [1764941457@qq.com](1764941457@qq.com)  \nProfessor Zili Lei, Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine, Guangdong Pharmaceutical University, 280 Wai‑Huan‑Dong Road, Guangzhou Higher Education Mega Center, Pan‑Yu, Guangzhou, Guangdong 510006, P.R. China  \nE‑mail: [3182683090@qq.com](3182683090@qq.com)  \n*Contributed equally  \nKey words: claudin‑7, tight junctions, regulation, epithelial‑related diseases  \n5. The physiological functions of CLDN7  \n6. CLDN7 and diseases  \n7. Conclusions and perspectives  \n1. Introduction  \nClaudin‑7 (CLDN7), a critical member of the claudin family, was first cloned and identified in mice by Morita et al in 1999 (1) . Its encoding gene maps to human chromosome 17p13.1 (2) . The CLDN7 protein structure comprises four transmembrane domains, two extracellular loops and a cytoplasmic tail region (3) . CLDN7 exhibits a specific expression pattern in human tissues . It is highly expressed in epithelial tissues such as the gastrointestinal tract, mammary glands, lungs and kidneys, while showing very low expression in neural and hematopoietic tissues, suggesting its close involvement in epithelial tissue differ‑ entiation and barrier maintenance (4) . Abnormal CLDN7 expression is strongly linked to tumorigenesis, proliferation and metastasis in cancers including colorectal cancer (CRC), lung cancer and breast cancer (5‑7) . Additionally, CLDN7 plays a crucial role in several non‑neoplastic diseases, such as respiratory disorders, intestinal diseases and skin conditions . For instance, CLDN7 is essential for intestinal epithelial cell function and self‑renewal and its absence leads to spontaneous colitis (8,9) . Reduced CLDN7 expres‑ sion levels may trigger excessive keratinocytes proliferation and impaired barrier function, contributing to psoriasis development (10,11) . CLDN7 is widely distributed in the respiratory barrier and is involved in respiratory diseases including allergic rhinitis, chronic obstructive pulmonary disease and asthma (12‑14) . However, there is currently a lack of comprehensive reviews on the role and mechanisms of CLDN7 in both neoplastic and non‑neoplastic diseases . The present review first ","cbCaioGWdZ3dVlUa","https://ap.wps.com/l/cbCaioGWdZ3dVlUa","pdf",4331127,13,"English","# Contents\n## 1. Introduction\n## 2. Methods\n## 3. Structure\n## 4. Expression and regulation of CLDN7\n## 5. The physiological functions of CLDN7\n## 6. CLDN7 and diseases\n## 7. Conclusions and perspectives","[{\"question\":\"What is the primary biological role of CLDN7 in epithelial cells?\",\"answer\":\"CLDN7 is a key component of epithelial tight junctions and helps maintain cell polarity, barrier integrity, and paracellular transport.\"},{\"question\":\"How is abnormal CLDN7 expression related to cancer?\",\"answer\":\"Abnormal CLDN7 expression is closely associated with the growth and metastasis of multiple cancers, and the review highlights its tumor-related expression patterns and regulatory mechanisms.\"},{\"question\":\"Which non-neoplastic diseases are associated with dysregulated CLDN7?\",\"answer\":\"The review links dysregulated CLDN7 to intestinal, skin, and respiratory system diseases, including examples such as colitis, psoriasis, and respiratory disorders.\"}]","CLDN7: Epithelial gatekeeper from physiology to pathology - roles in cancer and epithelial-related diseases - Review | PDF",1790086422,33,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/adeab824c4bd59fa7fffdcda3cff1be4.webp",983,1357,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d68232c5d8c0823b06ae73cc8064c7a7.webp",982,1356,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2321f8ae0ccccdf9622b9cd452f917b0.webp",981,1354,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eaec79c297a9a84363a03c1a4186b46f.webp",980,1353]